Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2022

View Archived Issues

Senescent neurons block neurogenesis in mice

SpFN vaccine confers protection in nonhuman primates against SARS-CoV-2

New TRPA1 antagonists discovered at Boehringer Ingelheim

New macrophage migration inhibitory factor inhibitors identified at Immunophage Biomedical

Scripps Research Institute, ShangPharma Innovation patent Rev-erbA-alpha/beta agonists

New three-prime repair exonuclease 1 inhibitors described by Tempest Therapeutics

Gene silencing using Toc-HDO technology ameliorated symptoms in EAE models

Researchers develop novel murine model of age-related macular degeneration

Targeting HO-1 signaling pathway against dengue hemorrhagic fever

Alpha Tau enters sponsored research agreement with MD Anderson to study Alpha DaRT in breast cancer

4E Therapeutics discloses new MNK1 and/or MNK2 inhibitors

Macolacin, a novel naturally inspired antibiotic with efficacy against MDR pathogens

Alzinova selects humanized lead candidate of monoclonal antibody ALZ-201

M1 muscarinic receptor mutant mice show accelerated prion neurodegeneration

Tevogen to study allogeneic T-cell technology for Epstein-Barr virus and MS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...